Immuron Limited cash flow statement IMRN
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMRN (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Carlton, Victoria, Australia
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1660046
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.